Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension.

Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Leonetti G, Sarti C, Tuomilehto J, Webster J, Yodfat Y; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Hypertension. 2004 Oct;44(4):459-64. Epub 2004 Aug 23.

2.

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.

Staessen JA, Thijisq L, Fagard R, Celis H, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Fletcher AE, Forette F, Leonetti G, McCormack P, Nachev C, O'Brien E, Rodicio JL, Rosenfeld J, Sarti C, Tuomilehto J, Webster J, Yodfat Y, Zanchetti A; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

J Hypertens. 2004 Apr;22(4):847-57.

PMID:
15126928
3.

Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension.

Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, de Leeuw PW, Jaaskivi M, Leonetti G, Nachev C, O'Brien ET, Parati G, Rodicio JL, Roman E, Sarti C, Tuomilehto J; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Arch Intern Med. 2002 Nov 11;162(20):2313-21.

PMID:
12418945
4.

Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial.

Fletcher AE, Bulpitt CJ, Thijs L, Tuomilehto J, Antikainen R, Bossini A, Browne J, Duggan J, Kawecka-Jaszcz K, Kivinen P, Sarti C, Terzoli L, Staessen JA; Syst-Eur Trial Investigators.

J Hypertens. 2002 Oct;20(10):2069-79.

PMID:
12359987
5.

Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial.

De Leeuw PW, Thijs L, Birkenhäger WH, Voyaki SM, Efstratopoulos AD, Fagard RH, Leonetti G, Nachev C, Petrie JC, Rodicio JL, Rosenfeld JJ, Sarti C, Staessen JA; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

J Am Soc Nephrol. 2002 Sep;13(9):2213-22.

6.

Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.

Staessen JA, Thijs L, Celis H, Gasowski J, Wang JG, Fagard RH; Systolic Hypertension in Europe Trial Investigators (the Syst-Eur Trial).

S Afr Med J. 2001 Dec;91(12):1060-8.

PMID:
11845604
7.

Ambulatory and conventional pulse pressures and mean pressures as determinants of the Sokolow-Lyon ECG voltage index in older patients with systolic hypertension.

Thijs L, O'Brien ET, Staessen JA; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Blood Press Monit. 2001 Aug;6(4):197-202. No abstract available.

PMID:
11805469
8.

Risk and benefit of treatment of isolated systolic hypertension in the elderly: evidence from the Systolic Hypertension in Europe Trial.

Celis H, Fagard RH, Staessen JA, Thijs L; Systolic Hypertension in Europe Trial Investigators.

Curr Opin Cardiol. 2001 Nov;16(6):342-8.

PMID:
11704703
9.

Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Voyaki SM, Staessen JA, Thijs L, Wang JG, Efstratopoulos AD, Birkenhäger WH, de Leeuw PW, Leonetti G, Nachev C, Rodicio JL, Tuomilehto J, Fagard R; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

J Hypertens. 2001 Mar;19(3):511-9.

PMID:
11288822

Supplemental Content

Loading ...
Support Center